منابع مشابه
Carbon ion therapy to debut in Europe.
fter 14 years of construction, the Large Hadron Collider, the world’s largest particle accelerator, fired its first beam of protons in September from its home at the European Organization for Nuclear Research (CERN) near Geneva. Now a spinoff technology for treating cancer is also nearing its European debut. The first European center to offer carbon ion therapy — a type of radiation treatment t...
متن کاملImpact of Various Beam Parameters on Lateral Scattering in Proton and Carbon-ion Therapy
Background: In radiation therapy with ion beams, lateral distributions of absorbed dose in the tissue are important. Heavy ion therapy, such as carbon-ion therapy, is a novel technique of high-precision external radiotherapy which has advantages over proton therapy in terms of dose locality and biological effectiveness.Methods: In this study, we used Monte Carlo method-based Geant4 toolkit to s...
متن کاملCarbon ion therapy for ameloblastic carcinoma
Ameloblastic carcinomas are rare odontogenic tumors. Treatment usually consists of surgical resection and sometimes adjuvant radiation. We report the case of a 71 year-old male patient undergoing carbon ion therapy for extensive local relapse of ameloblastic carcinoma. Treatment outcome was favourable with a complete remission at 6 weeks post completion of radiotherapy while RT-treatment itself...
متن کاملRBE and related modeling in carbon-ion therapy.
Carbon ion therapy is a promising evolving modality in radiotherapy to treat tumors that are radioresistant against photon treatments. As carbon ions are more effective in normal and tumor tissue, the relative biological effectiveness (RBE) has to be calculated by bio-mathematical models and has to be considered in the dose prescription. This review (i) introduces the concept of the RBE and its...
متن کاملDmd048355 814..826
The natural product fumagillin exhibits potent antiproliferative and antiangiogenic properties. The semisynthetic analog PPI-2458, [(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl) oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] N-[(2R)-1-amino-3-methyl-1oxobutan-2-yl]carbamate, demonstrates rapid inactivation of its molecular target, methionine aminopeptidase-2 (MetAP2), and good eff...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: RADIOISOTOPES
سال: 2019
ISSN: 0033-8303,1884-4111
DOI: 10.3769/radioisotopes.68.723